Statewide survey of the antimicrobial susceptibilities of Haemophilus influenzae producing invasive disease in Tennessee. 1983

T L Gustafson, and R A Kelley, and R H Hutcheson, and W Schaffner, and S H Sell

Between October 1, 1980, and September 30, 1981, a prospective statewide study of Haemophilus influenzae infections identified 220 culture-proved systemic infections. Of these, 92% were caused by H. influenzae type b. Antimicrobial susceptibility testing of the type b isolates showed that 17% were resistant to ampicillin, but virtually all were susceptible to chloramphenicol, trimethoprim-sulfamethoxazole, cefaclor and rifampin. Ampicillin resistance is common in all parts of Tennessee and chloramphenicol remains the drug of choice for initial therapy of systemic H. influenzae infections.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D008297 Male Males
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D002433 Cefaclor Semisynthetic, broad-spectrum antibiotic derivative of CEPHALEXIN. 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((aminophenylacetyl)amino)-3-chloro-8-oxo-, (6R-(6alpha,7beta(R*)))-,Ceclor,Cefaclor Anhydrous,Cefaclor Monohydrate,Keclor,Lilly 99638,S-6472,S 6472,S6472
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D002701 Chloramphenicol An antibiotic first isolated from cultures of Streptomyces venequelae in 1947 but now produced synthetically. It has a relatively simple structure and was the first broad-spectrum antibiotic to be discovered. It acts by interfering with bacterial protein synthesis and is mainly bacteriostatic. (From Martindale, The Extra Pharmacopoeia, 29th ed, p106) Cloranfenicol,Kloramfenikol,Levomycetin,Amphenicol,Amphenicols,Chlornitromycin,Chlorocid,Chloromycetin,Detreomycin,Ophthochlor,Syntomycin
D005260 Female Females
D006192 Haemophilus Infections Infections with bacteria of the genus HAEMOPHILUS. Hemophilus Infections,Haemophilus influenzae Infection,Haemophilus influenzae Type b Infection,Hib Infection,Infections, Haemophilus,Infections, Hemophilus,Haemophilus Infection,Haemophilus influenzae Infections,Hemophilus Infection,Hib Infections,Infection, Haemophilus,Infection, Haemophilus influenzae,Infection, Hemophilus,Infection, Hib

Related Publications

T L Gustafson, and R A Kelley, and R H Hutcheson, and W Schaffner, and S H Sell
July 1989, Journal of chemotherapy (Florence, Italy),
T L Gustafson, and R A Kelley, and R H Hutcheson, and W Schaffner, and S H Sell
January 2000, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases,
T L Gustafson, and R A Kelley, and R H Hutcheson, and W Schaffner, and S H Sell
June 2022, Microbiology spectrum,
T L Gustafson, and R A Kelley, and R H Hutcheson, and W Schaffner, and S H Sell
July 1994, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases,
T L Gustafson, and R A Kelley, and R H Hutcheson, and W Schaffner, and S H Sell
January 1992, Communicable disease report. CDR review,
T L Gustafson, and R A Kelley, and R H Hutcheson, and W Schaffner, and S H Sell
December 2004, The Journal of antimicrobial chemotherapy,
T L Gustafson, and R A Kelley, and R H Hutcheson, and W Schaffner, and S H Sell
February 1987, Archives of internal medicine,
T L Gustafson, and R A Kelley, and R H Hutcheson, and W Schaffner, and S H Sell
June 1988, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne,
T L Gustafson, and R A Kelley, and R H Hutcheson, and W Schaffner, and S H Sell
March 1988, Canada diseases weekly report = Rapport hebdomadaire des maladies au Canada,
T L Gustafson, and R A Kelley, and R H Hutcheson, and W Schaffner, and S H Sell
June 2000, Epidemiology and infection,
Copied contents to your clipboard!